Empery Asset Management’s Lixte Biotechnology Warrants LIXTW Stock Holding History

Empery Asset Management’s Portfolio LIXTW Stock Details LIXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-99,835	Closed	-$12K	–	90
2022 Q2	$12K	Sell	99,835 -5,428	-5%	-$1.1K	0.07%	60
2022 Q1	$20K	Buy	+105,263	New	+$27K	0.09%	65

Other funds holding LIXTW

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Empery Asset Management's LIXTW Position: Q3 2022 in Review

Empery Asset Management sold out of Lixte Biotechnology Warrants (LIXTW) in Q3 2022, closing a stake of 99,835 shares — an estimated $12K sold.

Empery Asset Management first reported a position in LIXTW in Q1 2022 and held it in 2 quarters. The position peaked at $20K in Q1 2022. 3 funds tracked by Wall St. Rank hold LIXTW as of Q3 2022.

Empery Asset Management reported no remaining Lixte Biotechnology Warrants position as of Q3 2022 after selling out during the quarter.
Empery Asset Management sold 99,835 Lixte Biotechnology Warrants shares in Q3 2022, an estimated $12K.
Empery Asset Management first reported a position in Lixte Biotechnology Warrants in Q1 2022 and held it in 2 quarters.
Empery Asset Management's Lixte Biotechnology Warrants position peaked at $20K in Q1 2022.
3 funds tracked by Wall St. Rank held Lixte Biotechnology Warrants as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.